Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2027 [Based on Japanese GAAP]11/12 15:30TDnetPDF(1,003KB)
Execution of JV and Share Transfer Agreement for Transfer of KYORIN Pharmaceutical’s Generic Drug Business to JV by Daito, Meiji Seika Pharma and DBJ9/30 15:30TDnetPDF(200KB)
ダイト、Meiji Seika ファルマ及び日本政策投資銀行が設立する共同出資会社による杏林製薬の後発医薬品事業の承継に関する合弁契約及び株式譲渡契約の締結9/30 15:30TDnetPDF(530KB)
Notice concerning Completion of Payment in Full and Partial Forfeiture of Rights for Disposal of Treasury Stock under Restricted Stock Incentive Plan9/25 15:30TDnetPDF(144KB)
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 [Based on Japanese GAAP]8/5 15:30TDnetPDF(2MB)
Notice concerning Completion of Payment in Full for Disposal of Treasury Stock for Restricted Stock Compensation for Directors7/31 15:30TDnetPDF(113KB)
Notice Concerning Transfer of Shares of Subsidiaries Associated with Restructuring of Business Portfolio in China7/21 17:10TDnetPDF(179KB)
Notice concerning the Disposal of Treasury Stock under Restricted Stock Incentive Plan for Employees in Managerial Positions7/3 15:30TDnetPDF(168KB)
Notice concerning the Disposal of Treasury Stock for Restricted Stock Compensation for Directors7/3 15:30TDnetPDF(133KB)